ArticleMolecular and cellular biochemistry2026
Galectin-3, transforming growth factor beta 1, and brain natriuretic peptide in cardiac remodeling under hyperlipidemic and hyperglycemic stress.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperlipidemia (HYL) and hyperglycemia (HYG) directly drive pathological cardiac remodeling; however, the mechanisms by which these conditions differentially regulate profibrotic signaling and early stress‑response pathways in left ventricular (LV) myocardium remain poorly defined. This study investigated the expression and localization of galectin-3 (Gal-3), transforming growth factor-β1 (TGF-β1), and brain natriuretic peptide (BNP) in a Yucatan miniswine model of HYL and HYG. Female Yucatan miniswine were assigned to normal control, HYL (high-cholesterol diet), or HYG (high-fat/high-carbohydrate diet plus low dose streptozotocin) groups (n = 6/group) for 8-weeks, and LV tissue was assessed by histology, qRT-PCR, Western blot, and immunohistochemistry. Both metabolic conditions induced cardiomyocyte hypertrophy and interstitial fibrosis, with more diffuse collagen deposition in HYG myocardium. qRT-PCR demonstrated upregulation of Gal-3, TGF-β1, and BNP relative to controls, with transcript levels positively correlating with circulating glucose concentration. Western blot analysis showed relatively greater active TGF-β1 signal in HYL myocardium and greater latent precursor accumulation in HYG myocardium, suggesting condition-associated differences in TGF-β1 regulation. Immunohistochemistry demonstrated perivascular Gal-3 localization, cytoplasmic and perinuclear TGF-β1 immunoreactivity in cardiomyocytes, and BNP immunoreactivity predominantly within subendocardial Purkinje fibers, with increased staining intensity in metabolically stressed groups compared with controls. Collectively, these findings suggest that HYL and HYG are associated with overlapping but distinct patterns of Gal-3, TGF-β1, and BNP expression during metabolic cardiac remodeling. The Gal-3/TGF-β1 axis may represent a shared profibrotic pathway, whereas BNP may reflect a compensatory stress response whose functional significance requires further mechanistic validation.
Indexed as
Identifiers
42384346What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.